Fullerene Derivatives for Tumor Treatment: Mechanisms and Application

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2024 Sep 30

PMID 39345909

Authors

Wenjia Hou

Lan Shen

Yimin Zhu

Xuanjia Wang

Tianyu Du

Fang Yang

Yabin Zhu

Affiliations

Soon will be listed here.

Abstract

Fullerenes hold tremendous potential as alternatives to conventional chemotherapy or radiotherapy for tumor treatment due to their abilities to photodynamically kill tumor cells, destroy the tumor vasculature, inhibit tumor metastasis and activate anti-tumor immune responses, while protecting normal tissue through antioxidative effects. The symmetrical hollow molecular structures of fullerenes with abundant C=C bonds allow versatile chemical modification with diverse functional groups, metal clusters and biomacromolecules to synthesize a wide range of fullerene derivatives with increased water solubility, improved biocompatibility, enhanced photodynamic properties and stronger targeting abilities. This review introduces the anti-tumor mechanisms of fullerenes and summarizes the most recent works on the functionalization of fullerenes and the application of fullerene derivatives in tumor treatment. This review aims to serve as a valuable reference for further development and clinical application of anti-tumor fullerene derivatives.

Citing Articles

Ferritin-Based Supramolecular Assembly Drug Delivery System for Aminated Fullerene Derivatives to Enhance Tumor-Targeted Therapy.

Zhang B, Yang L, Jin Y, Lu Y, Li J, Tang G Adv Sci (Weinh). 2024; 12(8):e2413389.

PMID: 39737845 PMC: 11848615. DOI: 10.1002/advs.202413389.

References

Liu X, Zheng M, Kong X, Zhang Y, Zeng Q, Sun Z . Separately doped upconversion-C60 nanoplatform for NIR imaging-guided photodynamic therapy of cancer cells. Chem Commun (Camb). 2013; 49(31):3224-6. DOI: 10.1039/c3cc41013g. View

Petrillo M, Patella F, Pesapane F, Suter M, Ierardi A, Angileri S . Hypoxia and tumor angiogenesis in the era of hepatocellular carcinoma transarterial loco-regional treatments. Future Oncol. 2018; 14(28):2957-2967. DOI: 10.2217/fon-2017-0739. View

Nakamura S, Mashino T . Water-soluble fullerene derivatives for drug discovery. J Nippon Med Sch. 2012; 79(4):248-54. DOI: 10.1272/jnms.79.248. View

Mroz P, Pawlak A, Satti M, Lee H, Wharton T, Gali H . Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. Free Radic Biol Med. 2007; 43(5):711-9. PMC: 1995806. DOI: 10.1016/j.freeradbiomed.2007.05.005. View

Huang P, Tang Q, Li M, Yang Q, Zhang Y, Lei L . Manganese-derived biomaterials for tumor diagnosis and therapy. J Nanobiotechnology. 2024; 22(1):335. PMC: 11179396. DOI: 10.1186/s12951-024-02629-8. View

Arnau Del Valle C, Hirsch T, Marin M . Recent advances in near infrared upconverting nanomaterials for targeted photodynamic therapy of cancer. Methods Appl Fluoresc. 2022; 10(3). DOI: 10.1088/2050-6120/ac6937. View

Chao M, Majeti R, Weissman I . Programmed cell removal: a new obstacle in the road to developing cancer. Nat Rev Cancer. 2011; 12(1):58-67. DOI: 10.1038/nrc3171. View

Yang D, Zhao Y, Guo H, Li Y, Tewary P, Xing G . [Gd@C(82)(OH)(22)](n) nanoparticles induce dendritic cell maturation and activate Th1 immune responses. ACS Nano. 2010; 4(2):1178-86. PMC: 2835518. DOI: 10.1021/nn901478z. View

Tang J, Pearce L, ODonnell-Tormey J, Hubbard-Lucey V . Trends in the global immuno-oncology landscape. Nat Rev Drug Discov. 2018; 17(11):783-784. DOI: 10.1038/nrd.2018.167. View

10.

Kang S, Zhou G, Yang P, Liu Y, Sun B, Huynh T . Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C82(OH)22 and its implication for de novo design of nanomedicine. Proc Natl Acad Sci U S A. 2012; 109(38):15431-6. PMC: 3458392. DOI: 10.1073/pnas.1204600109. View

11.

Juzeniene A, Nielsen K, Moan J . Biophysical aspects of photodynamic therapy. J Environ Pathol Toxicol Oncol. 2006; 25(1-2):7-28. DOI: 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.20. View

12.

Yang L, Yang X, Ji W, Deng J, Qiu F, Yang R . Effects of a functional variant c.353T>C in snai1 on risk of two contextual diseases. Chronic obstructive pulmonary disease and lung cancer. Am J Respir Crit Care Med. 2013; 189(2):139-48. DOI: 10.1164/rccm.201307-1355OC. View

13.

Tang Q, Xiao W, Li J, Chen D, Zhang Y, Shao J . A fullerene-rhodamine B photosensitizer with pH-activated visible-light absorbance/fluorescence/photodynamic therapy. J Mater Chem B. 2020; 6(18):2778-2784. DOI: 10.1039/c8tb00372f. View

14.

Carvalho C, Santos R, Cardoso S, Correia S, Oliveira P, Santos M . Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem. 2009; 16(25):3267-85. DOI: 10.2174/092986709788803312. View

15.

Sobotta L, Skupin-Mrugalska P, Piskorz J, Mielcarek J . Porphyrinoid photosensitizers mediated photodynamic inactivation against bacteria. Eur J Med Chem. 2019; 175:72-106. DOI: 10.1016/j.ejmech.2019.04.057. View

16.

Zhou Y, Zhen M, Guan M, Yu T, Ma L, Li W . Amino acid modified [70] fullerene derivatives with high radical scavenging activity as promising bodyguards for chemotherapy protection. Sci Rep. 2018; 8(1):16573. PMC: 6224443. DOI: 10.1038/s41598-018-34967-7. View

17.

Li Z, Pan L, Zhang F, Wang Z, Shen Y, Zhang Z . Preparation and characterization of fullerene (C60) amino acid nanoparticles for liver cancer cell treatment. J Nanosci Nanotechnol. 2014; 14(6):4513-8. DOI: 10.1166/jnn.2014.8242. View

18.

Trajkovic S, Dobric S, Jacevic V, Dragojevic-Simic V, Milovanovic Z, Dordevic A . Tissue-protective effects of fullerenol C60(OH)24 and amifostine in irradiated rats. Colloids Surf B Biointerfaces. 2007; 58(1):39-43. DOI: 10.1016/j.colsurfb.2007.01.005. View

19.

Markovic Z, Trajkovic V . Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60). Biomaterials. 2008; 29(26):3561-73. DOI: 10.1016/j.biomaterials.2008.05.005. View

20.

Sharma S, Chiang L, Hamblin M . Photodynamic therapy with fullerenes in vivo: reality or a dream?. Nanomedicine (Lond). 2011; 6(10):1813-25. PMC: 3433279. DOI: 10.2217/nnm.11.144. View